Covishield Roll-Out In Coming Weeks

His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZenca and Oxford. Poonawalla added the vaccine is safe, effective and ready for rollout.

migrator

Updated:3rd Jan, 2021 at 1:50 PM

New Delhi

Adar Poonawalla, CEO, Serum Institute of India (SII) said on Sunday that the Covishield, India's first Covid-19 vaccine will roll out in the coming weeks.

Poonawalla said SII risks on stockpiling the vaccine have paid off.

His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZenca and Oxford. Poonawalla added the vaccine is safe, effective and ready for rollout.

"Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks", he said in a tweet.

"Thank you Hon. Sri@narendramodiJi, Hon. Sri@drharshvardhanJi @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support", he added.

Covishield Roll-Out In Coming Weeks

His statement came minutes after the Drugs Controller General of India (DCGI) announced the approval for Covishield developed by AstraZenca and Oxford. Poonawalla added the vaccine is safe, effective and ready for rollout.

Also Read

3,550 special buses to ply crisscross TN for weekend, pournami rush

Jana Nayagan leak: Goondas Act against editor quashed

Delhi court grants default bail to 6 Ukrainians in Myanmar drone training camp case

Carney says Canada, India aim to wrap up trade talks by G20 ahead of Modi visit

Veeramani case under CM Vijay’s direct supervision, says Minister Rajmohan